Re:Cognition Health and Cera have partnered to expand access to Alzheimer’s clinical trials across the UK. The collaboration links Re:Cognition...
An experimental drug taken just once a month has shown promising results for weight loss and blood sugar control in people with obesity and type 2...
A daily low dose of aspirin is as effective as higher doses in reducing cancer risk for people with Lynch syndrome, according to new research. Lynch...
A biotechnology company developing a wearable, drug-free treatment for Alzheimer’s has raised US$1.33m in the first stage of a planned US$5m equity round. NeuroEM Therapeutics is...
The anti-ageing drug Rapamycin has been found to extend lifespan as effectively as reducing calorie intake, according to new research into longevity treatments. Rapamycin, originally developed...
Variability in heart rhythm during sleep may help detect early signs of stroke, depression or cognitive dysfunction – even in people who appear to sleep normally,...
A routine blood test may help identify which patients with early signs of Alzheimer’s are likely to deteriorate more rapidly, new research suggests. The test uses...
